Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines: Detected by RNA PCR-based quantitation assay

Sachi Takeda, Takao Shimazoe, Keiki Sato, Yoshikazu Sugimoto, Takashi Tsuruo, Akira Kono

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

RNA PCR quantitation method was developed to determine DNA Topoisomerase I(Topo I)-specific mRNA in order to study its gene expression in CPT-11 sensitive, acquired- or native-resistant human pancreatic tumor cell lines. The results were supported by Northern blotting and Western blotting analyses. Acquired-resistant cells have shown decreased levels of Topo I mRNA, compared with their parental cells. On the contrary, in the wild type cells no correlation was shown between sensitivity and gene expression. On the other specific Topo I activity of the native resistant cell lines was fairly lower than that of sensitive cell lines, suggesting that immunoreactive Tope I protein contains low levels of active form enzyme which could be targets of CPT-11 in these native-resistant ones. Finally, the different mechanisms might be operative between acquired- and native-resistant tumor cells.

Original languageEnglish
Pages (from-to)618-625
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume184
Issue number2
DOIs
Publication statusPublished - 1992 Apr 30
Externally publishedYes

Fingerprint

irinotecan
Type I DNA Topoisomerase
Tumor Cell Line
Tumors
Assays
Genes
Cells
RNA
Polymerase Chain Reaction
Gene expression
Gene Expression
Cell Line
Messenger RNA
Northern Blotting
Western Blotting
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines : Detected by RNA PCR-based quantitation assay. / Takeda, Sachi; Shimazoe, Takao; Sato, Keiki; Sugimoto, Yoshikazu; Tsuruo, Takashi; Kono, Akira.

In: Biochemical and Biophysical Research Communications, Vol. 184, No. 2, 30.04.1992, p. 618-625.

Research output: Contribution to journalArticle

@article{5fc9377636d3434aae1222156f06204a,
title = "Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines: Detected by RNA PCR-based quantitation assay",
abstract = "RNA PCR quantitation method was developed to determine DNA Topoisomerase I(Topo I)-specific mRNA in order to study its gene expression in CPT-11 sensitive, acquired- or native-resistant human pancreatic tumor cell lines. The results were supported by Northern blotting and Western blotting analyses. Acquired-resistant cells have shown decreased levels of Topo I mRNA, compared with their parental cells. On the contrary, in the wild type cells no correlation was shown between sensitivity and gene expression. On the other specific Topo I activity of the native resistant cell lines was fairly lower than that of sensitive cell lines, suggesting that immunoreactive Tope I protein contains low levels of active form enzyme which could be targets of CPT-11 in these native-resistant ones. Finally, the different mechanisms might be operative between acquired- and native-resistant tumor cells.",
author = "Sachi Takeda and Takao Shimazoe and Keiki Sato and Yoshikazu Sugimoto and Takashi Tsuruo and Akira Kono",
year = "1992",
month = "4",
day = "30",
doi = "10.1016/0006-291X(92)90634-W",
language = "English",
volume = "184",
pages = "618--625",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Differential expression of DNA topoisomerase I gene between CPT-11 acquired-and native-resistant human pancreatic tumor cell lines

T2 - Detected by RNA PCR-based quantitation assay

AU - Takeda, Sachi

AU - Shimazoe, Takao

AU - Sato, Keiki

AU - Sugimoto, Yoshikazu

AU - Tsuruo, Takashi

AU - Kono, Akira

PY - 1992/4/30

Y1 - 1992/4/30

N2 - RNA PCR quantitation method was developed to determine DNA Topoisomerase I(Topo I)-specific mRNA in order to study its gene expression in CPT-11 sensitive, acquired- or native-resistant human pancreatic tumor cell lines. The results were supported by Northern blotting and Western blotting analyses. Acquired-resistant cells have shown decreased levels of Topo I mRNA, compared with their parental cells. On the contrary, in the wild type cells no correlation was shown between sensitivity and gene expression. On the other specific Topo I activity of the native resistant cell lines was fairly lower than that of sensitive cell lines, suggesting that immunoreactive Tope I protein contains low levels of active form enzyme which could be targets of CPT-11 in these native-resistant ones. Finally, the different mechanisms might be operative between acquired- and native-resistant tumor cells.

AB - RNA PCR quantitation method was developed to determine DNA Topoisomerase I(Topo I)-specific mRNA in order to study its gene expression in CPT-11 sensitive, acquired- or native-resistant human pancreatic tumor cell lines. The results were supported by Northern blotting and Western blotting analyses. Acquired-resistant cells have shown decreased levels of Topo I mRNA, compared with their parental cells. On the contrary, in the wild type cells no correlation was shown between sensitivity and gene expression. On the other specific Topo I activity of the native resistant cell lines was fairly lower than that of sensitive cell lines, suggesting that immunoreactive Tope I protein contains low levels of active form enzyme which could be targets of CPT-11 in these native-resistant ones. Finally, the different mechanisms might be operative between acquired- and native-resistant tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=0026683277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026683277&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(92)90634-W

DO - 10.1016/0006-291X(92)90634-W

M3 - Article

C2 - 1315526

AN - SCOPUS:0026683277

VL - 184

SP - 618

EP - 625

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -